动态增强CT与PET/CT在孤立性肺结节定性中的准确性与成本效益比较
这项前瞻性多中心试验纳入380例8-30 mm孤立性肺结节患者,比较动态增强CT(DCE-CT)与PET/CT的诊断准确性和成本效益。312例完成研究,2年恶性率61%。PET/CT的AUROC为0.80,优于DCE-CT的0.62;两者联合AUROC达0.90。
要点
- PET/CT对孤立性肺结节的诊断准确性优于DCE-CT。
- DCE-CT敏感性高但特异性低,PET/CT特异性更高。
- 联合两种技术可提高诊断准确性并可能具有成本效益。
核心结论
- PET/CT对孤立性肺结节的诊断准确性优于DCE-CT。
- 联合两种技术可提高诊断准确性并可能具有成本效益。
研究设计与样本
- 前瞻性多中心试验纳入380例8-30 mm孤立性肺结节且无近期恶性肿瘤史的患者,均接受DCE-CT和PET/CT检查。
- 所有患者接受活检组织学诊断或完成CT随访,312例完成研究。
主要发现
- 312例完成研究者中女性47%,年龄68.1±9.0岁,2年恶性率为61%。
- DCE-CT的敏感性95.3%(95%CI 91.3-97.5)、特异性29.8%(95%CI 22.3-38.4)、阳性预测值68.2%(95%CI 62.4%-73.5%)、阴性预测值80.0%(95%CI 66.2-89.1)。
- PET/CT的敏感性79.1%(95%CI 72.7-84.2)、特异性81.8%(95%CI 74.0-87.7)、阳性预测值87.3%(95%CI 81.5-91.5)、阴性预测值71.2%(95%CI 63.2-78.1)。
- DCE-CT与PET/CT的AUROC分别为0.62(95%CI 0.58-0.67)和0.80(95%CI 0.76-0.85),p<0.001。
- 联合结果较单独PET/CT显著提高诊断准确性,AUROC=0.90(95%CI 0.86-0.93),p<0.001。
关键数值与推荐
- 当每增量成本下正确治疗恶性肿瘤的支付意愿低于9000英镑时,DCE-CT更受偏好。
临床怎么用
- 对于孤立性肺结节,可优先考虑PET/CT以获得更高的诊断准确性。
- 在支付意愿较高的情形下,联合DCE-CT与PET/CT可进一步提高诊断准确性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Dynamic contrast-enhanced CT (DCE-CT) and positron emission tomography/CT (PET/CT) have a high reported accuracy for the diagnosis of malignancy in solitary pulmonary nodules (SPNs). The aim of this study was to compare the accuracy and cost-effectiveness of these. METHODS: In this prospective multicentre trial, 380 participants with an SPN (8-30 mm) and no recent history of malignancy underwent DCE-CT and PET/CT. All patients underwent either biopsy with histological diagnosis or completed CT follow-up. Primary outcome measures were sensitivity, specificity and overall diagnostic accuracy for PET/CT and DCE-CT. Costs and cost-effectiveness were estimated from a healthcare provider perspective using a decision-model. RESULTS: 312 participants (47% female, 68.1±9.0 years) completed the study, with 61% rate of malignancy at 2 years. The sensitivity, specificity, positive predictive value and negative predictive values for DCE-CT were 95.3% (95% CI 91.3 to 97.5), 29.8% (95% CI 22.3 to 38.4), 68.2% (95% CI 62.4% to 73.5%) and 80.0% (95% CI 66.2 to 89.1), respectively, and for PET/CT were 79.1% (95% CI 72.7 to 84.2), 81.8% (95% CI 74.0 to 87.7), 87.3% (95% CI 81.5 to 91.5) and 71.2% (95% CI 63.2 to 78.1). The area under the receiver operator characteristic curve (AUROC) for DCE-CT and PET/CT was 0.62 (95% CI 0.58 to 0.67) and 0.80 (95% CI 0.76 to 0.85), respectively (p<0.001). Combined results significantly increased diagnostic accuracy over PET/CT alone (AUROC=0.90 (95% CI 0.86 to 0.93), p<0.001). DCE-CT was preferred when the willingness to pay per incremental cost per correctly treated malignancy was below £9000. Above £15 500 a combined approach was preferred. CONCLUSIONS: PET/CT has a superior diagnostic accuracy to DCE-CT for the diagnosis of SPNs. Combining both techniques improves the diagnostic accuracy over either test alone and could be cost-effective. TRIAL REGISTRATION NUMBER: NCT02013063.
引用
- Gilbert FJ, Harris S, Miles KA, et al. Comparative accuracy and cost-effectiveness of dynamic contrast-enhanced CT and positron emission tomography in the characterisation of solitary pulmonary nodules. Thorax. 2021. PMID: 34887348. doi:10.1136/thoraxjnl-2021-216948
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。